MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Clinical trials for MALIGNANT GENITOURINARY SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GENITOURINARY SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT GENITOURINARY SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to tame Immunotherapy's gut side effects
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, for treating colitis (colon inflammation) caused by immune checkpoint inhibitor cancer therapy. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer who develop moderate to severe diarr…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:05 UTC
-
New combo therapy targets Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase study tests two or three drugs together (cabozantinib, nivolumab, and sometimes ipilimumab) in people with advanced cancers of the urinary and genital systems that have spread. The main goals are to find the safest dose and understand side effects. About 152 adul…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:01 UTC